FDA Approves Orforglipron (Foundayo): First No-Restriction GLP-1 Pill
The FDA approved orforglipron, marketed as Foundayo, on April 1, 2026 — the first GLP-1 pill that can be taken any time of day without food or water restrictions. Phase 3 data show up to 12.4% mean weight loss.